Erythromycin 500 Mg Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets/Capsules
Available Strengths: 250 mg, 500 mg, 600 mg
Reference Brands: Erythrocin, Erythrocin V, Erythrocin Stearate(US), Althrocin (India)
Category:
Antibiotics
Erythromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation. It is effective against respiratory, skin, and soft tissue infections. Benefits include reliable, broad-spectrum activity, good tissue penetration, and convenient oral dosing, making it a trusted choice for treating various bacterial infections.
Erythromycin 500 mg tablets is available in Oral Tablets/Capsules
and strengths such as 250 mg, 500 mg, 600 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Erythromycin 500 mg tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Erythromycin 500 mg tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Erythromycin tablets are approved in the EU and US for treating respiratory, skin, and soft tissue bacterial infections. In the EU, brands like Erythrocin and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for erythromycin tablets, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing